Hensley PJ - Search Results

1

TGF-β receptor I inhibitor enhances response to enzalutamide in a pre-clinical model of advanced prostate cancer.

Paller C, Pu H, Begemann DE, Wade CA, Hensley PJ, Kyprianou N. Paller C, et al. Among authors: hensley pj. Prostate. 2019 Jan;79(1):31-43. doi: 10.1002/pros.23708. Epub 2018 Aug 28. Prostate. 2019. PMID: 30155899 Free PMC article.

2

Patient and Carer Experiences with Bladder Cancer: Results from a Global Survey in 45 Countries.

Makaroff LE, Filicevas A, Boldon S, Hensley P, Black PC, Chisolm S, Demkiw S, Fernández MI, Sugimoto M, Jensen BT, Witjes WPJ, Bagshaw K, Cirefice-Funk L, Knight A, Kamat AM. Makaroff LE, et al. Eur Urol. 2023 Aug;84(2):248-251. doi: 10.1016/j.eururo.2023.04.034. Epub 2023 May 24. Eur Urol. 2023. PMID: 37236857 No abstract available.

3

Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship.

Hensley PJ, Duan Z, Bree K, Sood A, Zhao H, Lobo N, Contieri R, Campbell MT, Guo CC, Navai N, Williams SB, Dinney CP, Kamat AM. Hensley PJ, et al. Urol Oncol. 2023 Feb;41(2):108.e11-108.e17. doi: 10.1016/j.urolonc.2022.10.015. Epub 2022 Nov 17. Urol Oncol. 2023. PMID: 36404232

4

Modeling prostate cancer in mice: limitations and opportunities.

Hensley PJ, Kyprianou N. Hensley PJ, et al. J Androl. 2012 Mar-Apr;33(2):133-44. doi: 10.2164/jandrol.111.013987. Epub 2011 Jun 16. J Androl. 2012. PMID: 21680808 Free PMC article. Review.

5

Targeting caspases in cancer therapeutics.

Hensley P, Mishra M, Kyprianou N. Hensley P, et al. Biol Chem. 2013 Jul;394(7):831-43. doi: 10.1515/hsz-2013-0128. Biol Chem. 2013. PMID: 23509217 Free PMC article. Review.

6

Novel pharmacologic targeting of tight junctions and focal adhesions in prostate cancer cells.

Hensley PJ, Desiniotis A, Wang C, Stromberg A, Chen CS, Kyprianou N. Hensley PJ, et al. PLoS One. 2014 Jan 31;9(1):e86238. doi: 10.1371/journal.pone.0086238. eCollection 2014. PLoS One. 2014. PMID: 24497940 Free PMC article.

7

PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis.

Pu H, Horbinski C, Hensley PJ, Matuszak EA, Atkinson T, Kyprianou N. Pu H, et al. Among authors: hensley pj. Carcinogenesis. 2014 Nov;35(11):2592-601. doi: 10.1093/carcin/bgu183. Epub 2014 Aug 30. Carcinogenesis. 2014. PMID: 25173886 Free PMC article.

8

Association of epithelial-mesenchymal transition and nuclear cofilin with advanced urothelial cancer.

Hensley PJ, Zetter D, Horbinski CM, Strup SE, Kyprianou N. Hensley PJ, et al. Hum Pathol. 2016 Nov;57:68-77. doi: 10.1016/j.humpath.2016.06.020. Epub 2016 Jul 8. Hum Pathol. 2016. PMID: 27402302 Free PMC article.

9

Predictive value of epithelial-mesenchymal-transition (EMT) signature and PARP-1 in prostate cancer radioresistance.

Stark TW, Hensley PJ, Spear A, Pu H, Strup SS, Kyprianou N. Stark TW, et al. Among authors: hensley pj. Prostate. 2017 Dec;77(16):1583-1591. doi: 10.1002/pros.23435. Epub 2017 Oct 23. Prostate. 2017. PMID: 29063620

10

Nuclear spindles pave the way to metastasis.

Hensley PJ, Kyprianou N. Hensley PJ, et al. Oncotarget. 2017 Dec 27;9(16):12544-12545. doi: 10.18632/oncotarget.23728. eCollection 2018 Feb 27. Oncotarget. 2017. PMID: 29560085 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page